UnknownNCT02727881
Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD
PHASE3 · 230 planned enrolment
- Countries listed
- 1
- Registry update
- April 27, 2017
immortal.lifeTrial registrations containing the exact intervention label Squalamine lactate ophthalmic solution, 0.2%.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE3 · 230 planned enrolment
PHASE2 · 0 planned enrolment